440 related articles for article (PubMed ID: 20050373)
1. Molecular mechanisms of melatonin anticancer effects.
Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
[TBL] [Abstract][Full Text] [Related]
2. Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5.
Xiang S; Mao L; Yuan L; Duplessis T; Jones F; Hoyle GW; Frasch T; Dauchy R; Blask DE; Chakravarty G; Hill SM
J Pineal Res; 2012 Oct; 53(3):307-18. PubMed ID: 22582905
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
[TBL] [Abstract][Full Text] [Related]
4. The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation.
Lai L; Yuan L; Chen Q; Dong C; Mao L; Rowan B; Frasch T; Hill SM
J Pineal Res; 2008 Nov; 45(4):476-88. PubMed ID: 18705646
[TBL] [Abstract][Full Text] [Related]
5. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
6. Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth.
Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Blask DE
Curr Aging Sci; 2013 Feb; 6(1):125-33. PubMed ID: 23895529
[TBL] [Abstract][Full Text] [Related]
7. Melatonin: an inhibitor of breast cancer.
Hill SM; Belancio VP; Dauchy RT; Xiang S; Brimer S; Mao L; Hauch A; Lundberg PW; Summers W; Yuan L; Frasch T; Blask DE
Endocr Relat Cancer; 2015 Jun; 22(3):R183-204. PubMed ID: 25876649
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
Treeck O; Haldar C; Ortmann O
Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
[TBL] [Abstract][Full Text] [Related]
9. Rhythms in clock proteins in the mouse pars tuberalis depend on MT1 melatonin receptor signalling.
Jilg A; Moek J; Weaver DR; Korf HW; Stehle JH; von Gall C
Eur J Neurosci; 2005 Dec; 22(11):2845-54. PubMed ID: 16324119
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effects of melatonin on breast cancer].
Jiang Z; Ma F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):346-351. PubMed ID: 28364111
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins.
Kiefer TL; Lai L; Yuan L; Dong C; Burow ME; Hill SM
J Pineal Res; 2005 May; 38(4):231-9. PubMed ID: 15813899
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
13. Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma.
Jablonska K; Pula B; Zemla A; Owczarek T; Wojnar A; Rys J; Ambicka A; Podhorska-Okolow M; Ugorski M; Dziegiel P
J Pineal Res; 2013 Apr; 54(3):334-45. PubMed ID: 23330677
[TBL] [Abstract][Full Text] [Related]
14. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
Blask DE; Dauchy RT; Brainard GC; Hanifin JP
Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
[TBL] [Abstract][Full Text] [Related]
15. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.
León J; Casado J; Carazo A; Sanjuán L; Maté A; Muñoz de Rueda P; de la Cueva P; Quiles R; Ruíz S; Ruíz-Extremera A; Salmerón J
Mol Carcinog; 2012 Aug; 51(8):608-18. PubMed ID: 21809392
[TBL] [Abstract][Full Text] [Related]
16. 17Beta-estradiol modulates hMT1 melatonin receptor function.
Masana MI; Soares JM; Dubocovich ML
Neuroendocrinology; 2005; 81(2):87-95. PubMed ID: 15809517
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
Girgert R; Hanf V; Emons G; Gründker C
Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA
Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
[TBL] [Abstract][Full Text] [Related]
19. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
Mao L; Yuan L; Slakey LM; Jones FE; Burow ME; Hill SM
Breast Cancer Res; 2010; 12(6):R107. PubMed ID: 21167057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
